Important Notice to Long-Term Shareholders of Fluor Corporation ( NYSE: FLR ) ; Humana Inc. ( NYSE: HUM ) ; Maison Solutions Inc. ( NASDAQ: MSS ) ; and Vestis Corp. ( NYSE: VSTS ) : Grabar Law Office is Investigating Claims on Your Behalf - Humana ( NYSE:HUM ) , Fluor ( NYSE:FLR )
PHILADELPHIA, Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Fluor Corporation ( NYSE:FLR ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Humana ( HUM ) Moves 4.0% Higher: Will This Strength Last?
Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Humana Benefits From Rising Premiums Amid High Benefit Ratio
HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.
George Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab Farmacêutica licensing agreement in Brazil
Biolab Farmacêutica gains exclusive rights in Brazil to GMRx2, an innovative single pill combination of three medicines, including two doses that are lower than those currently available in single pill combinations, designed to deliver the blood pressure-lowering benefits of triple combination ...
Is Humana ( HUM ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Akero Therapeutics ( AKRO ) Stock Outpacing Its Medical Peers This Year?
Here is how Akero Therapeutics, Inc. (AKRO) and Humana (HUM) have performed compared to their sector so far this year.
Grant Cardone's 10X Health President Kent Bradley Backs $4.5M AI Brain Therapy Startup That Improves Cognitive Function By 18%
Moneta Health, a brain health startup delivering AI-powered cognitive rehabilitation therapy, has secured $4.5 million in funding. The company is advised by Kent Bradley, president of 10X Health, which was co-founded by entrepreneur Grant Cardone.
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.
Medicare Advantage enrollment expected to fall in 2026 as insurers cut back on unprofitable plans
CMS sees Medicare Advantage enrollment falling in 2026, as insurers facing lower profits cut back on unprofitable plans ...
HUMANA ( HUM ) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Humana ( NYSE:HUM )
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana ( HUM ) To Contact Him Directly To Discuss Their Options
Humana Unusual Options Activity - Humana ( NYSE:HUM )
High-rolling investors have positioned themselves bearish on Humana HUM, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.
Humana Extends TailorCare Tie-Up to Enhance MA Member Health
HUM expands its TailorCare partnership to Dallas and Denver, aiming to boost MA member health and cut MSK-related costs.
The Trump administration is changing Covid, childhood vaccine recommendations - here's what it means for you
Several health experts say there are steps Americans can take to navigate the new guidance and try to secure the vaccines they or their children want or need.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
This GATX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Argan ( NYSE:AGX ) , GATX ( NYSE:GATX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
RFK Jr.'s vaccine panel weakens Covid shot recommendations, calling it an individual decision
The group also voted to emphasize that the Covid vaccine is beneficial for those at high risk of severe illness from the disease.
Zacks Industry Outlook Highlights Cigna and Humana
Cigna and Humana stand out in the HMO space, leveraging growth platforms and Medicare demand despite cost and regulatory pressures.
HUMANA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humana Inc. - HUM - Humana ( NYSE:HUM )
NEW ORLEANS, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( "KSF" ) , announces that KSF has commenced an investigation into Humana Inc. ( "Humana" or "the Company" ) HUM.
2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs
The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.
Confluent Health Strengthens Leadership to Advance Innovation and Culture in MSK Care
LOUISVILLE, Ky., Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- Confluent Health, a national leader in musculoskeletal ( MSK ) care, today announced it has named Scott Farnsworth, MIHS, LPN, PMP, as Chief Information Officer ( CIO ) and John Lacy as Chief People Officer ( CPO ) .
Covid shot access, coverage at stake as RFK Jr.'s hand-picked vaccine panel convenes
Some experts warn that weakening recommendations for Covid vaccines and other shots could make it harder for some people to access jabs and have them covered.
Will UnitedHealth's Push for Access to Trump Calm Investor Jitters?
UNH doubles lobbying spend, reshapes legal team and seeks Trump access amid regulatory risks.
Should SPDR Russell 1000 Low Volatility Focus ETF ( ONEV ) Be on Your Investing Radar?
Style Box ETF report for ...
Is SPDR Russell 1000 Low Volatility Focus ETF ( ONEV ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares
HUM scoops up $68M Florida care centers, but star rating hurdles send shares tumbling 12%. Can HUM turn risk into reward?
UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points
UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.
Humana ( HUM ) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UnitedHealth & AI: Can Technology Redefine Healthcare Efficiency?
UNH is leveraging AI to streamline insurance and care delivery, aiming to boost efficiency and improve patient outcomes.
These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025
One of these stocks could still be a good buy today thanks to an improving growth rate and a long history of strong financial results.
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure
CVS' Health Care Benefit arm shines in Q2, driven by government plans, even as ACA exit and utilization pressures weigh.
Is Humana Gaining or Losing Market Support? - Humana ( NYSE:HUM )
Humana's HUM short percent of float has risen 12.36% since its last report. The company recently reported that it has 5.27 million shares sold short, which is 4.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their ...
Is ELV's Push Beyond Insurance a Blueprint for the Healthcare Future?
Elevance Health expands beyond insurance into primary care, digital health and pharmacy services, aiming to reshape healthcare delivery.
Why Is Humana ( HUM ) Up 19.2% Since Last Earnings Report?
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members.
Here's Why Humana ( HUM ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Strategic Contracts and Partnerships Centene's Growth Engine?
Centene's growth hinges on government contracts and strategic partnerships, but shares have plunged over 52% this year.
Centene Faces HBR Pressures: Will Scale Support Stability?
CNC's rising HBR, driven by higher medical costs and policy shifts, pressures margins as it leans on scale and efficiency for stability.
UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?
UNH expands behavioral health with Optum's digital tools, partnerships and integrated care to tap rising demand.
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
UnitedHealth's Expansion Into ASCs: Redefining the Operating Room
UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.
Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?
Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.
CNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?
Humana's strong Medicare Advantage growth and higher ROE give it an edge over Centene, which faces earnings pressure and OBBB Act headwinds.
UnitedHealth's Push Into Home Health: A New Growth Chapter?
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
CORRECTION - Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
IRVINE, Calif., Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- MorningStar Laboratories, LLC., ( "MSL" or "the Company" ) , a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today corrections to the second paragraph of its press release under the same headline ...
Why Is UnitedHealth Group Stock Gaining Monday? - UnitedHealth Group ( NYSE:UNH )
BofA forecasts UnitedHealth earnings rebound by 2027, raising target to $325. The 2027 Medicare Advantage update and Star Ratings will shape profitability. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan Stanley, and more.
Here's Why Humana ( HUM ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Humana, DrFirst Ties Up to Boost Statin Use in High-Risk Patients
HUM partners with DrFirst to increase statin use in high-risk patients with diabetes and cardiovascular disease, aiming to close care gaps.
Is CNC Banking on Membership Growth to Boost Scale & Profitability?
Centene's growing membership base boosts revenue scale and operational efficiency, even as medical inflation puts pressure on margins.
SelectQuote ( SLQT ) Faces Investor Securities Class Action After Stock Dropped 19% Amid Department of Justice Alleges False Claims Act Violations - Hagens Berman - SelectQuote ( NYSE:SLQT )
SAN FRANCISCO, Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- After investors in SelectQuote ( NYSE:SLQT ) saw the price of their shares tumble over 19% on May 1, 2025 when the U.S. Department of Justice announced it had intervened in a lawsuit against the company, a securities class action lawsuit, styled ...
Is the Market Bullish or Bearish on Humana? - Humana ( NYSE:HUM )
Humana's HUM short percent of float has risen 9.8% since its last report. The company recently reported that it has 4.68 million shares sold short, which is 4.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.93 days to cover their ...
